SCYX
Price
$0.89
Change
-$0.06 (-6.32%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
55.88M
34 days until earnings call
TXMD
Price
$0.94
Change
-$0.06 (-6.00%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
24.32M
33 days until earnings call
Ad is loading...

SCYX vs TXMD

Header iconSCYX vs TXMD Comparison
Open Charts SCYX vs TXMDBanner chart's image
SCYNEXIS
Price$0.89
Change-$0.06 (-6.32%)
Volume$193
Capitalization55.88M
TherapeuticsMD
Price$0.94
Change-$0.06 (-6.00%)
Volume$200
Capitalization24.32M
SCYX vs TXMD Comparison Chart
Loading...
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TXMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SCYX vs. TXMD commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCYX is a Hold and TXMD is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (SCYX: $0.89 vs. TXMD: $0.97)
Brand notoriety: SCYX and TXMD are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: SCYX: 103% vs. TXMD: 7%
Market capitalization -- SCYX: $55.88M vs. TXMD: $24.32M
SCYX [@Pharmaceuticals: Other] is valued at $55.88M. TXMD’s [@Pharmaceuticals: Other] market capitalization is $24.32M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SCYX’s FA Score shows that 0 FA rating(s) are green whileTXMD’s FA Score has 0 green FA rating(s).

  • SCYX’s FA Score: 0 green, 5 red.
  • TXMD’s FA Score: 0 green, 5 red.
According to our system of comparison, TXMD is a better buy in the long-term than SCYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SCYX’s TA Score shows that 3 TA indicator(s) are bullish while TXMD’s TA Score has 5 bullish TA indicator(s).

  • SCYX’s TA Score: 3 bullish, 6 bearish.
  • TXMD’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TXMD is a better buy in the short-term than SCYX.

Price Growth

SCYX (@Pharmaceuticals: Other) experienced а -11.69% price change this week, while TXMD (@Pharmaceuticals: Other) price change was -7.62% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.02%. For the same industry, the average monthly price growth was -2.23%, and the average quarterly price growth was -10.29%.

Reported Earning Dates

SCYX is expected to report earnings on May 08, 2025.

TXMD is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-4.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SCYX($55.9M) has a higher market cap than TXMD($24.3M). SCYX has higher P/E ratio than TXMD: SCYX (1.06) vs TXMD (0.47). TXMD YTD gains are higher at: 12.791 vs. SCYX (-26.289). SCYX has higher annual earnings (EBITDA): 70.9M vs. TXMD (52.6M). SCYX has more cash in the bank: 74.4M vs. TXMD (10.2M). TXMD has less debt than SCYX: TXMD (8.2M) vs SCYX (15.1M). SCYX has higher revenues than TXMD: SCYX (140M) vs TXMD (69.4M).
SCYXTXMDSCYX / TXMD
Capitalization55.9M24.3M230%
EBITDA70.9M52.6M135%
Gain YTD-26.28912.791-206%
P/E Ratio1.060.47224%
Revenue140M69.4M202%
Total Cash74.4M10.2M729%
Total Debt15.1M8.2M184%
FUNDAMENTALS RATINGS
SCYX vs TXMD: Fundamental Ratings
SCYX
TXMD
OUTLOOK RATING
1..100
1012
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9793
PRICE GROWTH RATING
1..100
8461
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TXMD's Valuation (50) in the Pharmaceuticals Generic industry is in the same range as SCYX (55) in the Pharmaceuticals Other industry. This means that TXMD’s stock grew similarly to SCYX’s over the last 12 months.

TXMD's Profit vs Risk Rating (100) in the Pharmaceuticals Generic industry is in the same range as SCYX (100) in the Pharmaceuticals Other industry. This means that TXMD’s stock grew similarly to SCYX’s over the last 12 months.

TXMD's SMR Rating (93) in the Pharmaceuticals Generic industry is in the same range as SCYX (97) in the Pharmaceuticals Other industry. This means that TXMD’s stock grew similarly to SCYX’s over the last 12 months.

TXMD's Price Growth Rating (61) in the Pharmaceuticals Generic industry is in the same range as SCYX (84) in the Pharmaceuticals Other industry. This means that TXMD’s stock grew similarly to SCYX’s over the last 12 months.

SCYX's P/E Growth Rating (98) in the Pharmaceuticals Other industry is in the same range as TXMD (100) in the Pharmaceuticals Generic industry. This means that SCYX’s stock grew similarly to TXMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SCYXTXMD
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 18 days ago
80%
Bullish Trend 2 days ago
69%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TXMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAK3.63-0.07
-1.89%
Braskem SA
SIFY4.49-0.16
-3.44%
Sify Technologies Ltd
FICO1801.05-88.84
-4.70%
Fair Isaac Corp
GDEN24.96-2.50
-9.10%
Golden Entertainment
BIAF0.71-0.19
-20.75%
bioAffinity Technologies

SCYX and

Correlation & Price change

A.I.dvisor tells us that SCYX and CRON have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCYX and CRON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCYX
1D Price
Change %
SCYX100%
-6.12%
CRON - SCYX
29%
Poorly correlated
-1.66%
ITCI - SCYX
29%
Poorly correlated
N/A
TXMD - SCYX
29%
Poorly correlated
-3.00%
ACET - SCYX
27%
Poorly correlated
-7.32%
OGI - SCYX
27%
Poorly correlated
-4.79%
More

TXMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, TXMD has been loosely correlated with LIEN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if TXMD jumps, then LIEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TXMD
1D Price
Change %
TXMD100%
-3.00%
LIEN - TXMD
36%
Loosely correlated
+0.50%
DRRX - TXMD
32%
Poorly correlated
-1.39%
SCYX - TXMD
29%
Poorly correlated
-6.12%
ASRT - TXMD
27%
Poorly correlated
+1.49%
ACB - TXMD
23%
Poorly correlated
-4.14%
More